glp-1 retatrutide Retatrutide, a GIP, and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Diagram showing the mechanism of

Fennema D, Phillips IR, Shephard EA Drug metabolism and disposition: the biological fate of chemicals 2016

Daily Injections Weekly injectables include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), tirzepatide (Mounjaro, Zepbound) and exenatide extended release (Bydureon BCise)

The accumulation of intracellular iron during ferroptosis is important in leukemic cells

d) Brain and Nerve Benefits They may protect against neuroinflammation , helping in conditions like Alzheimers and Parkinsons

For patients meeting NICE criteria for weight management therapy (BMI 35 kg/m with adjustment for ethnicity, presence of weight-related comorbidities, and treatment through specialist weight management services), the dual benefit of weight reduction and blood pressure lowering may be particularly valuable